WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
300760 Shenzhen Mindray Bio-Medical Electronics
- 225.27
- -4.59-2.00%
Market Closed Apr 3 15:00 CST
273.13BMarket Cap22.05P/E (TTM)
230.49High225.11Low107.04KlotVolume228.00Open229.86Pre Close2.43BTurnover0.88%Turnover Ratio23.58P/E (Static)1.21BShares349.9552wk High7.78P/B273.13BFloat Cap219.0052wk Low275.83Limit Up1.21BShs Float482.50Historical High183.89Limit Down2.34%Amplitude34.06Historical Low7.21Dividend TTM226.84Avg Price45.07KlotAsk3.20%Div YieldTTM100Lot Size48.74KlotBid
Shenzhen Mindray Bio-Medical Electronics Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -12.04%17.3B | 1.97%20.6B | -11.34%21.19B | -18.97%18.79B | 27.39%19.67B | 67.70%20.2B | 60.46%23.91B | 50.94%23.19B | 20.09%15.44B | -22.97%12.05B |
| Transactional financial assets | --360.97M | --188.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | -1.80%3.61B | 8.58%4.02B | 37.86%3.7B | 23.90%3.3B | 18.27%3.67B | 15.17%3.71B | 17.34%2.68B | 48.62%2.66B | 50.60%3.1B | 67.46%3.22B |
| -Notes receivable | -95.72%2.19M | 4,751.83%68.77M | 1,922.41%48.21M | -18.59%1.7M | -14.18%51.12M | -98.32%1.42M | -96.84%2.38M | -98.41%2.09M | -55.30%59.56M | 62.18%84.28M |
| -Accounts receivable | -0.48%3.6B | 6.76%3.96B | 36.18%3.65B | 23.94%3.3B | 18.91%3.62B | 18.22%3.71B | 21.23%2.68B | 60.29%2.66B | 57.91%3.05B | 67.61%3.13B |
| Other receivables (including interest and dividends) | 0.21%187.62M | 35.52%252.59M | 139.03%279.84M | 30.84%195.1M | 5.49%187.22M | 18.00%186.39M | -20.47%117.07M | 18.31%149.11M | -56.14%177.47M | -58.31%157.95M |
| -Other receivable | ---- | 35.52%252.59M | ---- | ---- | ---- | 18.00%186.39M | ---- | 18.31%149.11M | ---- | 61.41%157.95M |
| Advance payment | 7.82%337.18M | 0.60%323.72M | -27.24%251.34M | -7.48%267.79M | 2.77%312.74M | 16.35%321.78M | 42.77%345.43M | 21.68%289.43M | 32.17%304.31M | 46.27%276.56M |
| Inventories | 20.62%4.86B | 2.12%4.52B | -18.71%3.96B | -1.15%3.98B | -3.01%4.03B | 12.25%4.43B | 25.28%4.87B | 12.89%4.02B | 25.77%4.15B | 17.07%3.94B |
| Non-current assets due within one year | 12.77%43.56M | 12.90%41.13M | 25.86%40.69M | 30.82%41.63M | 27.20%38.63M | 27.69%36.43M | 22.60%32.33M | 20.67%31.82M | 19.61%30.37M | 15.04%28.53M |
| Other current assets | 15.71%412.01M | 13.42%377.83M | -6.83%325.22M | 16.67%308.07M | 48.77%356.07M | 77.72%333.12M | 101.99%349.08M | 21.13%264.06M | 90.67%239.34M | 39.50%187.44M |
| Total current assets | -4.09%27.1B | 3.82%30.33B | -7.91%29.75B | -12.19%26.88B | 20.53%28.26B | 47.10%29.21B | 49.01%32.3B | 43.45%30.61B | 23.37%23.45B | -8.30%19.86B |
| Non Current assets | ||||||||||
| Other equity investment | 45.59%239.31M | 48.71%245.77M | 1,224.82%133.29M | --142.82M | --164.37M | --165.27M | --10.06M | ---- | ---- | ---- |
| Other non-current financial assets | ---- | ---- | --1.4B | --1.27B | --1.25B | --1.11B | ---- | ---- | ---- | ---- |
| Investment real estate | -4.49%40.07M | -4.44%40.54M | -4.39%41.01M | -4.35%41.49M | -4.30%41.96M | -4.25%42.43M | -4.21%42.9M | -4.17%43.37M | 15.93%43.84M | 15.89%44.31M |
| Long-term equity investment | 105.65%137.98M | 112.12%138.09M | -1.85%63.46M | 9.48%66.56M | 8.93%67.09M | 8.00%65.1M | 4.83%64.66M | 130.69%60.8M | 162.61%61.6M | 150.99%60.28M |
| Long term receivable account | -14.42%11.94M | -22.43%10.97M | -52.46%8.4M | -56.72%10.94M | -64.18%13.95M | -69.69%14.14M | -45.66%17.67M | -26.81%25.28M | 21.34%38.94M | 143.23%46.66M |
| Fixed assets | ---- | 33.90%6.43B | ---- | ---- | ---- | 25.77%4.81B | ---- | 12.97%4.26B | ---- | 13.33%3.82B |
| Constru in process | ---- | 44.63%2.6B | ---- | ---- | ---- | 27.06%1.8B | ---- | 60.05%1.8B | ---- | 24.28%1.42B |
| Intangible assets | 234.71%6.81B | 235.34%6.65B | 13.38%2.22B | 12.56%2.22B | 6.72%2.03B | 6.55%1.98B | 2.62%1.96B | -4.10%1.98B | -7.01%1.91B | 71.59%1.86B |
| Development expenditure | 37.60%405.6M | -3.21%342.38M | 2.34%324.43M | 15.31%342.35M | 33.27%294.77M | 65.25%353.75M | 77.49%317.01M | 111.98%296.9M | -20.90%221.17M | -22.99%214.07M |
| Goodwill | 148.61%11.21B | 140.38%11.15B | 12.66%4.98B | 14.95%5.06B | 6.19%4.51B | 10.76%4.64B | 6.26%4.42B | 4.38%4.4B | -2.47%4.24B | 244.95%4.19B |
| Long deferred expense | -19.44%61.71M | -2.50%70.3M | -13.80%67.68M | -9.29%74.88M | -12.71%76.6M | -20.75%72.1M | -2.56%78.51M | -1.93%82.55M | -0.56%87.75M | 201.17%90.98M |
| Deferred tax assets | 53.79%1.27B | 65.10%1.28B | 65.33%1.18B | 73.87%1.31B | 26.14%827.43M | 26.95%775.12M | 50.38%714.01M | 26.60%755.08M | 35.02%655.95M | 37.36%610.57M |
| Usufruct assets | 11.65%277.41M | 19.72%275.74M | 14.24%262.3M | 19.71%270.37M | 4.11%248.45M | -0.72%230.33M | 2.58%229.6M | -3.17%225.85M | 7.46%238.64M | 8.17%232.01M |
| Other non current assets | -85.10%727.25M | -53.48%1.06B | 2.88%2.28B | 4.01%2.29B | -6.90%4.88B | -63.17%2.28B | -50.64%2.22B | -50.21%2.21B | 17.81%5.24B | 41.01%6.2B |
| Total non current assets | 40.34%30.5B | 65.29%30.3B | 29.69%21.09B | 30.52%21.06B | 19.34%21.73B | -2.39%18.33B | -2.41%16.26B | -3.75%16.14B | 9.57%18.21B | 53.28%18.78B |
| Total assets | 15.22%57.6B | 27.52%60.63B | 4.68%50.83B | 2.56%47.94B | 20.01%49.99B | 23.05%47.54B | 26.66%48.56B | 22.68%46.75B | 16.93%41.66B | 13.96%38.64B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --5.68M | --3.48M | --4.91M | --7.75M | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 48.09%3.81B | 29.22%3.88B | -2.78%2.83B | 17.45%2.69B | -6.12%2.57B | 9.34%3B | 16.67%2.91B | 0.42%2.29B | 50.43%2.74B | 60.56%2.75B |
| -Accounts payable | 48.09%3.81B | 29.22%3.88B | -2.78%2.83B | 17.45%2.69B | -6.12%2.57B | 9.34%3B | 16.67%2.91B | 0.42%2.29B | 50.43%2.74B | 60.56%2.75B |
| Contract liabilities | -8.89%1.72B | -16.54%2.08B | -47.05%2.06B | -52.37%1.97B | 11.68%1.89B | 24.21%2.5B | 78.66%3.89B | 72.03%4.14B | -14.91%1.69B | -12.18%2.01B |
| Advance receipts | -15.37%1.35M | 27,924.98%4.38M | 2,129.97%3.88M | 163.73%793.44K | 300.71%1.59M | -92.24%15.64K | -54.46%173.8K | 29.80%300.85K | --396.66K | --201.54K |
| Salaries payable | 14.04%3.04B | 31.25%3.33B | 28.79%2.99B | 4.83%2.27B | 7.78%2.66B | 5.64%2.54B | 4.56%2.32B | 22.09%2.16B | 21.38%2.47B | 34.42%2.4B |
| Taxs payable | -19.84%683.72M | 34.64%1.01B | 180.25%824.76M | 13.92%653.24M | 48.06%852.97M | 5.38%748.38M | -14.51%294.3M | 21.06%573.4M | 15.88%576.09M | 74.99%710.16M |
| Other payable (including interest and dividends) | 8.15%1.8B | 21.12%2.07B | 18.48%1.86B | 7.35%2.04B | 10.25%1.67B | 13.74%1.71B | 34.48%1.57B | 45.25%1.9B | 28.88%1.51B | 19.00%1.51B |
| -Dividend payable | ---- | --100.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 15.27%1.97B | ---- | ---- | ---- | 13.74%1.71B | ---- | 45.25%1.9B | ---- | 19.00%1.51B |
| Non current liabilities due within one year | 15.92%115.6M | 9.10%110.11M | 2.75%101.02M | 7.73%104.73M | 1.86%99.73M | 10.78%100.93M | 15.65%98.32M | 14.26%97.22M | 29.53%97.91M | 35.92%91.11M |
| Other current liabilities | -1.17%380.71M | -0.84%410.16M | -24.91%390.16M | -39.44%364.52M | 12.36%385.2M | 33.38%413.64M | 64.14%519.57M | 100.15%601.87M | 17.12%342.82M | 4.70%310.12M |
| Total current liabilities | 14.08%11.56B | 17.19%12.91B | -4.66%11.07B | -14.16%10.1B | 7.42%10.13B | 12.65%11.01B | 31.78%11.61B | 36.40%11.77B | 19.57%9.43B | 24.90%9.78B |
| Current liabilities | ||||||||||
| Long term loan | --376.31K | --385.54K | --973.9K | --1.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term salaries pay | -15.22%1.82B | -15.33%1.81B | 22.96%1.8B | 36.22%2.94B | 79.13%2.15B | 133.94%2.14B | 83.84%1.46B | 19.26%2.16B | -0.86%1.2B | -2.36%914.27M |
| Estimate liabilities | 86.43%511.34M | 93.77%522.38M | 104.99%501.95M | 121.01%512.62M | 23.79%274.28M | 27.67%269.58M | 27.07%244.86M | 24.19%231.94M | 15.96%221.57M | 15.16%211.15M |
| Deferred tax liabilities | 404.76%838.93M | 385.39%860.84M | -2.95%170.62M | -8.06%168.36M | -8.11%166.2M | -5.25%177.35M | -7.46%175.81M | -8.63%183.13M | -21.54%180.87M | 340.25%187.17M |
| Long term deferred income | 21.33%121.34M | 31.80%132.38M | 34.23%116.72M | 17.61%109.31M | 20.17%100.01M | 21.67%100.44M | -16.10%86.95M | -11.56%92.94M | -5.72%83.22M | -46.27%82.55M |
| Lease liabilities | 11.09%179.18M | 29.95%183.92M | 24.27%176.1M | 29.98%181.07M | 8.12%161.29M | -4.68%141.53M | -1.31%141.7M | -8.44%139.31M | -0.17%149.18M | -0.91%148.47M |
| Other non current liabilities | 194.06%557.02M | 182.81%556.95M | 245.58%568.51M | 241.78%575.37M | 11.35%189.43M | 83.59%196.93M | 227.67%164.51M | 238.57%168.35M | 240.72%170.11M | 148.40%107.27M |
| Total non current liabilities | 32.58%4.03B | 34.49%4.07B | 46.45%3.33B | 50.90%4.49B | 51.65%3.04B | 83.22%3.02B | 54.24%2.27B | 18.77%2.98B | 4.45%2B | 9.41%1.65B |
| Total liabilities | 18.35%15.59B | 20.91%16.97B | 3.71%14.4B | -1.03%14.59B | 15.17%13.17B | 22.84%14.04B | 35.00%13.89B | 32.43%14.75B | 16.61%11.44B | 22.39%11.43B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | -0.27%1.21B | -0.27%1.21B | -0.27%1.21B |
| Capital reserve funds | -6.78%6.94B | -6.55%6.91B | -6.24%7.13B | -5.57%7.09B | 0.44%7.44B | 1.16%7.39B | 5.44%7.6B | -7.90%7.51B | -9.11%7.41B | -10.35%7.31B |
| Surplus reserve funds | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M | 0.00%607.85M |
| Retained profit | 1.55%28.58B | 22.93%30.42B | 5.73%27.84B | 3.87%24.68B | 26.44%28.14B | 27.29%24.75B | 28.50%26.33B | 29.23%23.76B | 30.55%22.26B | 31.99%19.44B |
| Less:Treasury stock | -51.62%324.77M | -51.07%328.44M | -33.67%663.28M | -33.67%663.28M | -32.87%671.26M | -32.87%671.26M | 0.00%999.99M | 0.00%999.99M | 0.00%999.99M | --999.99M |
| Other composite income | -6.51%84.19M | -88.64%24.21M | 145.54%47.33M | 244.19%157.27M | 131.61%90.05M | 156.33%213.1M | 78.84%-103.93M | 73.38%-109.07M | -27.69%-284.87M | -151.31%-378.32M |
| Shareholders equity without minority interests | 0.74%37.09B | 15.95%38.85B | 4.39%36.17B | 3.45%33.09B | 21.92%36.82B | 23.21%33.5B | 23.62%34.65B | 18.65%31.98B | 17.06%30.2B | 10.74%27.19B |
| Minority interests | --4.92B | --4.8B | 1,213.37%256.22M | 1,325.33%260.65M | ---- | ---- | 13.80%19.51M | 19.97%18.29M | 19.75%18.2M | 25.72%17.38M |
| Total shareholder equity | 14.10%42.01B | 30.29%43.65B | 5.07%36.43B | 4.21%33.35B | 21.85%36.82B | 23.13%33.5B | 23.61%34.67B | 18.66%32B | 17.06%30.22B | 10.75%27.21B |
| Total liabilityies and equity | 15.22%57.6B | 27.52%60.63B | 4.68%50.83B | 2.56%47.94B | 20.01%49.99B | 23.05%47.54B | 26.66%48.56B | 22.68%46.75B | 16.93%41.66B | 13.96%38.64B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.